Amh Equity LTD Scynexis Inc Transaction History
Amh Equity LTD
- $91.4 Million
- Q4 2024
A detailed history of Amh Equity LTD transactions in Scynexis Inc stock. As of the latest transaction made, Amh Equity LTD holds 626,052 shares of SCYX stock, worth $694,917. This represents 0.79% of its overall portfolio holdings.
Number of Shares
626,052
Previous 600,000
4.34%
Holding current value
$694,917
Previous $894,000
19.57%
% of portfolio
0.79%
Previous 1.24%
Shares
7 transactions
Others Institutions Holding SCYX
# of Institutions
53Shares Held
12.7MCall Options Held
9KPut Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA2.9MShares$3.21 Million0.01% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$2.48 Million0.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.84 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.23MShares$1.36 Million0.16% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$616,6660.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $36.2M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...